School of Health and Social Development/Institute for Health Transformation, Deakin University, Australia; Centre for Sport Research, Deakin University, Australia.
College of Health and Human Sciences, Charles Darwin University, Australia; School of Applied Psychology, Griffith University, Australia.
J Sci Med Sport. 2023 Nov;26(11):574-579. doi: 10.1016/j.jsams.2023.08.179. Epub 2023 Aug 25.
There is limited research into the use of performance and image enhancing drugs among women who participate in sport, despite evidence that women do use these substances and experience related harms. The aim of this project is to capture stakeholder perspectives on the current research, policy, and practice landscape in Australia regarding women's performance and image enhancing drug use in regulated and unregulated sport settings.
Qualitative interviews.
Thirty-two semi-structured interviews were conducted online with stakeholders from Australia between September and December 2021. Interviews ranged between 15 and 90 min in duration. Data were imported into the NVivo (Version 12) platform and analysed using thematic analysis.
Thirty-two participants (20 females and 12 males) who held a variety of roles (e.g., coach/strength coaches, gym owners, anti-doping agents, athletes) were interviewed. Fourteen participants reported performance and image enhancing drug use. There were four overarching themes generated from the data: 'participation in untested sports'; 'environmental factors driving use'; 'individual rationalisation'; and, 'the dark side of performance and image enhancing drug use'.
Performance and image enhancing drug use was identified as an issue of concern for women competing in non-elite strength and power-based sports. Of particular concern is the influence of unqualified advice from third parties (i.e., coaches and partners) regarding performance and image enhancing drug use. The environments in which performance and image enhancing drug use occurs can impact individual decisions of women and eventuate in significant and long-lasting physical and psychological harms.
尽管有证据表明女性确实使用这些物质并因此遭受相关危害,但针对参与体育运动的女性使用表现和形象增强药物的研究还很有限。本项目旨在了解利益相关者对澳大利亚在监管和非监管运动环境中针对女性在表现和形象增强方面药物使用的当前研究、政策和实践情况的看法。
定性访谈。
2021 年 9 月至 12 月期间,在线对来自澳大利亚的利益相关者进行了 32 次半结构化访谈。访谈时间在 15 到 90 分钟之间不等。数据被输入到 NVivo(第 12 版)平台中,并使用主题分析进行分析。
32 名参与者(20 名女性和 12 名男性)具有各种角色(例如教练/力量教练、健身房老板、反兴奋剂机构、运动员),接受了采访。其中 14 名参与者报告了表现和形象增强药物的使用情况。从数据中产生了四个总体主题:“参加未经测试的运动”;“推动使用的环境因素”;“个人合理化”;以及“表现和形象增强药物使用的阴暗面”。
表现和形象增强药物的使用被认为是参加非精英力量和基于力量运动的女性关注的问题。特别令人担忧的是,来自第三方(即教练和伴侣)的关于表现和形象增强药物使用的不合格建议的影响。表现和形象增强药物使用发生的环境会影响女性的个人决策,并导致严重和持久的身体和心理伤害。